#FDAApproved
LightNews LightNews
thefda.bsky.social
ideal meal for maximum nutrition #FDAapproved
January 8, 2025 at 8:21 PM
justinfreakin.bsky.social
FDA Nominee Dr. Heidi Overton Refuses To Say Trump Can be Wrong

#fdaapproved #news #politicstiktok #trump #senate
September 24, 2026 at 5:23 PM
drsinicropipodcast.bsky.social
Most people with low back pain are told to rest.
But the truth is, active recovery matters especially building up core strength.
#emsculptneo #backpainrelief #corestrength #spinehealth #hyperchargehealth #integrativehealth #recoverytools #fdaapproved #drsinicropi #wellness #minnesota #twincities
June 27, 2025 at 12:25 PM
onclive.bsky.social
BREAKING‼️@US_FDA Approves Datopotamab Deruxtecan for Unresectable or Metastatic HR+/HER2-Negative Breast Cancer #bcsm #oncology #FDAapproved onclive.com/view/fda-app...
January 17, 2025 at 6:48 PM
onclive.bsky.social
BREAKING 🚨: @fda.gov Grants Accelerated Approval to Dato-DXd for EGFR+ NSCLC

Read more here 📰: onclive.com/view/fda-gra...

#lcsm #oncology #FDAapproved
June 23, 2025 at 6:07 PM
onclive.bsky.social
BREAKING 🚨: @fda.gov Grants Accelerated Approval to Zongertinib for Nonsquamous NSCLC With HER2 TKD Mutations

Read more 📰: www.onclive.com/view/fda-gra...

#lcsm #oncology #FDAapproved
August 8, 2025 at 5:41 PM
oncodaily.bsky.social
Enfortumab Vedotin (Padcev): Uses in Cancer, Side Effects, Dosage, Expectations, and More

oncodaily.com/drugs/enfort...

#AdvancedUrothelialCarcinoma #BladderCancer #Cancer #CancerTreatment #Drugs #FDAApproved #Medicine #Health #EnfortumabVedotin #OncoDaily #Oncology #Padcev #TargetTherapy
Enfortumab Vedotin (Padcev), Uses, side effects, expectation
Enfortumab Vedotin (Padcev) treats advanced urothelial cancer. Learn about its uses, dosage, side effects, and what to expect during treatment.
oncodaily.com
March 14, 2025 at 5:17 PM
onclive.bsky.social
BREAKING🚨: @fda.gov Approves Belzutifan for Advanced Pheochromocytoma and Paraganglioma #FDAapproved #btsm #oncology
onclive.com/view/fda-app...
May 14, 2025 at 4:27 PM
ofheal.bsky.social
Embark on your weight-loss journey with Zepbound, the FDA-approved aid for managing weight concerns. 🌟 Shed up to 20.2% body weight with effortless weekly shots and proven results. Take control of your health and boost your confidence. 💪 🔗 Learn more: buff.ly/FBOFrKu #WellnessJourney #FDAApproved
What Is wepbound and How It Works for Weight Loss
July 22, 2025 at 2:00 PM
onclive.bsky.social
BREAKING: 🚨 @fda.gov Approves Linvoseltamab for Relapsed/Refractory Multiple Myeloma

Read the full article here 📰: www.onclive.com/view/fda-app...

#mmsm #oncology #FDAapproved
July 2, 2025 at 4:21 PM
cancercommunicator.com
#FDA approves T-DXd for unresectable or metastatic HR+/ HER2-low (IHC 1+ or IHC 2+/ISH-) or HER2-ultralow (IHC 0 with membrane staining) breast cancer that has progressed on one or more endocrine therapies in the metastatic setting based DESTINY-Breast06. #FDAapproved #bcsm #Oncsky #cansky @fda.gov
January 29, 2025 at 12:32 AM
ai-portal-post.bsky.social
Did you know AI can now spot hidden heart failure from your routine ECG, *before* you even have symptoms? The FDA just cleared EchoNext, an incredible system that could revolutionize preventative cardiology and sa…

#ArtificialIntelligence #HealthcareInnovation #FDAapproved #HeartHealth #MedicalTech
FDA-Cleared AI Reads Your Routine ECG and Flags Hidden Heart Failure Before You Have Any Symptoms
AI-Powered ECG Analysis Clears FDA Hurdle The FDA has cleared EchoNext, an AI system designed to analyze routine electrocardiograms (ECGs) and flag hidden heart failure,…
news.owkid.com
September 27, 2026 at 7:38 AM
tomkindlon.bsky.social
New:
Molecular hydrogen as a treatment for ME/CFS: a mini-review of clinical evidence and mechanistic rationale

Free fulltext:
www.frontiersin.org/journals/med...

#MEcfs #CFS #PwME #MyalgicEncephalomyelitis #ChronicFatigueSyndrome
Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating multisystem illness characterized by profound fatigue, post-exertional malaise, cognitive impairment, and autonomic dysfunction, yet it currently lacks FDAapproved treatments. Molecular hydrogen (H2), administered primarily as hydrogen-rich water (HRW), has emerged as a potential therapeutic candidate due to its selective antioxidant effects, anti-inflammatory activity, and support of mitochondrial and cellular homeostasis. These mechanisms align with several biological abnormalities implicated in ME/CFS, including oxidative stress, chronic inflammation, and impaired energy metabolism. This narrative minireview summarizes mechanistic evidence relevant to ME/CFS and evaluates three developmental clinical studies of HRW in this population. Although early trials are small and methodologically limited, moderate-dose HRW consumed over extended durations has demonstrated feasibility and preliminary benefits in reducing fatigue and improving physical function, with generally mild side effects. Overlapping findings in Long COVID further suggest potential applicability across related post-viral fatigue conditions. Key limitations include small sample sizes, reliance on self-report outcomes, and the absence of objective biomarkers. Future research should prioritize larger, rigorously controlled trials incorporating remote biometric and biochemical assessments to clarify mechanisms of action and identify responsive subgroups. Overall, molecular hydrogen represents a promising, low-burden adjunctive therapy warranting further investigation in ME/CFS.
March 18, 2026 at 2:01 PM
mrcalabunga.bsky.social
2025 is gonna be a strange year, eh? #cinnamontoastcrunch #cereal #breakfast #FDAapproved #milkisjustliquidcheeseanywayright?
January 24, 2025 at 12:06 AM
onclive.bsky.social
BREAKING 🚨: @fda.gov Approves Retifanlimab for Advanced Anal Cancer #FDAapproved #oncology

Learn more: www.onclive.com/view/fda-app...
May 15, 2025 at 6:50 PM
kangarootammer01.bsky.social
www.tiktok.com/t/ZTrhSG8aA/
The Truth They Hide Inside Goldfish Snacks #campbells #goldfishcrackers #fdaapproved #horror #fyp @Ad Infernum
TikTok video by Ad Infernum
www.tiktok.com
November 29, 2025 at 2:59 AM
cancercommunicator.com
The HER2:HER3 bispecific Ab #zenocutuzumab was #FDAapproved for advanced, unresectable, or metastatic NRG1 fusion+ NSCLC (ORR 33%; mDOR 7.4 mo) and NRG1 fusion+ pancreatic adenocarcinoma (ORR 40%; DOR 3.7-16.6 mo) after 1 systemic Tx #lcsm #pancan #oncsky #cansky #pansm bit.ly/41lRFwW @fda.gov
FDA grants accelerated approval to zenocutuzumab-zbco
On December 4, 2024, the FDA granted accelerated approval to zenocutuzumab-zbco for non-small cell lung cancer and pancreatic adenocarcinoma.
bit.ly
December 5, 2024 at 2:05 PM
onclive.bsky.social
BREAKING 📢: @fda.gov Grants Accelerated Approval to Telisotuzumab Vedotin In Pretreated Advanced NSCLC With c-MET Overexpression #lcsm #oncology #FDAapproved

Read more here: onclive.com/view/fda-gra...
May 14, 2025 at 6:01 PM
onclive.bsky.social
BREAKING 🚨: @fda.gov Approves Subcutaneous Daratumumab for High-Risk Smoldering Multiple Myeloma

Read all about it 📰: onclive.com/view/fda-app...

#mmsm #FDAapproved #oncology
November 6, 2025 at 8:12 PM
onclive.bsky.social
BREAKING NEWS 🚨: @fda.gov Grants Full Approval to Tarlatamab ES-SCLC 🫁

Read more about this decision here 📰: onclive.com/view/fda-gra...

#lcsm #oncology #FDAapproved
November 19, 2025 at 7:53 PM
cancercommunicator.com
Durvalumab #FDAapproved for pts w/ LS-SCLC whose disease has not progressed following concurrent pt-based chemoradiotherapy based on #ADRIATIC (mOS, 56 vs 37 mo durva vs pbo) #lcsm #oncsky #cansky #oncosky @fda.gov bit.ly/49p1Dj9
FDA approves durvalumab for limited-stage small cell lung cancer
On December 4, 2024, the Food and Drug Administration approved durvalumab (Imfinzi, AstraZeneca) for limited-stage small cell lung cancer (LS-SCLC).
bit.ly
December 5, 2024 at 1:47 PM
onclive.bsky.social
BREAKING 🚨: @fda.gov Grants Full Approval to Encorafenib Plus Cetuximab/Chemotherapy for BRAF V600E+ mCRC

Check out the article below to learn more about this regulatory decision! 👇 #crcsm #oncology #FDAapproved

onclive.com/view/fda-gra...
February 24, 2026 at 6:49 PM
new-atlas.bsky.social
The FDA has approved Onapgo, a groundbreaking treatment for Parkinson's disease, set for 2025 release. This advancement could change patient care significantly. Read more: https://bit.ly/40MrqxB
#ParkinsonsTreatment #FDAapproved #InnovativeTechnology
US approves "milestone" Parkinson's treatment for 2025 release
Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease. The US FDA this week approved the sale of the treatment, which harnesses innovative...
bit.ly
February 5, 2025 at 8:10 AM
onclive.bsky.social
BREAKING 🚨: @fda.gov Approves Relacorilant Plus Nab-Paclitaxel for Platinum-Resistant Ovarian Cancer

Learn more about the data behind this regulatory decision in the article below! 📰

#ovca #oncology #FDAapproved
onclive.com/view/fda-app...
March 25, 2026 at 2:45 PM
purescience.news
FDA-Approved Sleeping Pill Slows Alzheimer's Tangles in Pre-Clinical Trial #Science #HealthandMedicine #Neurology #AlzheimersResearch #SleepHealth #FDAApproved
FDA-Approved Sleeping Pill Slows Alzheimer's Tangles in Pre-Clinical Trial
All the science news you can handle in a single feed
purescience.news
June 19, 2025 at 9:27 PM